Marc Carrier Selected Research

Marc Carrier Research Topics

Disease

106	Neoplasms (Cancer) 05/2024 - 01/2008
96	Venous Thromboembolism 05/2024 - 12/2002
92	Hemorrhage 05/2024 - 05/2010
51	Thrombosis (Thrombus) 11/2023 - 01/2003
26	Venous Thrombosis (Deep-Vein Thrombosis) 09/2023 - 01/2003
17	Pulmonary Embolism 01/2023 - 01/2006
16	COVID-19 01/2022 - 01/2020
13	Atrial Fibrillation 11/2023 - 09/2011
11	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2007
7	Critical Illness (Critically Ill) 01/2022 - 08/2016
6	Obesity 03/2024 - 01/2020
6	Thromboembolism 01/2022 - 01/2018
5	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2020 - 12/2002
4	Stroke (Strokes) 11/2023 - 06/2014
4	Neoplasm Metastasis (Metastasis) 02/2023 - 07/2013
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 08/2018
3	Upper Extremity Deep Vein Thrombosis 12/2023 - 02/2015
3	Thrombophilia 11/2023 - 06/2010
3	Infections 01/2022 - 07/2020
3	Subacute Sclerosing Panencephalitis (SSPE) 11/2020 - 12/2017
3	Pregnancy Complications 02/2014 - 06/2010
2	Vascular System Injuries 09/2023 - 02/2014
2	Leukemia 07/2023 - 12/2020
2	Wounds and Injuries (Trauma) 01/2023 - 01/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022 - 01/2022
2	Sepsis (Septicemia) 01/2022 - 06/2017
2	Inflammation (Inflammations) 01/2022 - 07/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 02/2014
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 12/2016
2	Embolism (Embolus) 11/2019 - 06/2014
2	Chronic Disease (Chronic Diseases) 01/2019 - 10/2018
2	Abruptio Placentae (Placental Abruption) 07/2011 - 06/2010
2	Pre-Eclampsia (Preeclampsia) 07/2011 - 06/2010
1	Spinal Injuries (Spinal Injury) 03/2024
1	Thromboinflammation 09/2023

Drug/Important Bio-Agent (IBA)

106	AnticoagulantsIBA 04/2024 - 02/2009
54	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2024 - 01/2003
26	apixabanIBA 04/2024 - 08/2013
23	RivaroxabanIBA 05/2024 - 08/2013
19	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2003
14	Vitamin K FDA Link 10/2022 - 08/2013
10	fibrin fragment D (D-dimer)IBA 01/2022 - 01/2006
9	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 06/2013
9	edoxabanIBA 12/2021 - 06/2014
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2020
7	Factor Xa InhibitorsIBA 07/2023 - 11/2015
7	Warfarin (Coumadin)FDA LinkGeneric 07/2021 - 09/2009
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020 - 06/2013
6	Dabigatran FDA Link 03/2021 - 08/2013
5	Prothrombin (Factor II)IBA 11/2023 - 06/2010
5	Hemostatics (Antihemorrhagics)IBA 07/2023 - 11/2020
4	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 08/2013
3	factor V LeidenIBA 11/2023 - 12/2002
3	prothrombin complex concentrates (PPSB)IBA 07/2023 - 11/2020
3	Thrombin FDA Link 07/2023 - 01/2023
3	VaccinesIBA 01/2023 - 01/2021
3	AntibodiesIBA 01/2023 - 01/2007
3	CreatinineIBA 01/2022 - 07/2015
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2021
3	ORALIT (ORS)IBA 12/2021 - 06/2010
3	Fondaparinux (Arixtra)FDA Link 01/2021 - 09/2014
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2023 - 08/2016
2	COVID-19 VaccinesIBA 01/2023 - 01/2022
2	C-Reactive ProteinIBA 01/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 01/2023 - 09/2021
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2023 - 01/2023
2	Troponin T (Troponin T1)IBA 07/2022 - 04/2013
2	pro-brain natriuretic peptide (1-76)IBA 07/2022 - 04/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2022 - 01/2022
2	Tinzaparin (Innohep)FDA Link 01/2022 - 12/2011
2	Oxygen (Dioxygen)IBA 01/2022 - 04/2017
2	Fibrinogen (Factor I)FDA Link 07/2021 - 03/2021
2	Asparaginase (Elspar)FDA Link 12/2020 - 01/2020
2	Neutralizing AntibodiesIBA 10/2020 - 07/2020
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 07/2020 - 06/2014
2	AntithrombinsIBA 01/2020 - 01/2019
2	Nadroparin (Nadroparin Calcium)IBA 01/2020 - 12/2016
2	coumarinIBA 05/2019 - 07/2012
2	boldenone undecylenate (Equipoise)IBA 01/2017 - 01/2015
1	Tranexamic Acid (AMCA)FDA Link 03/2024
1	fibrinogen gamma'IBA 11/2023
1	SerpinsIBA 11/2023
1	InflammasomesIBA 09/2023
1	Colchicine FDA LinkGeneric 09/2023
1	canakinumab FDA Link 09/2023

Therapy/Procedure

67	Therapeutics 04/2024 - 01/2003
35	Drug Therapy (Chemotherapy) 11/2023 - 02/2012
8	Catheters 12/2023 - 09/2012
7	Central Venous Catheters 12/2023 - 02/2015
6	Contraindications 01/2022 - 02/2012
4	Duration of Therapy 07/2022 - 02/2012
4	Artificial Respiration (Mechanical Ventilation) 01/2022 - 10/2020
3	Secondary Prevention 04/2017 - 08/2013
2	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2023 - 01/2018
2	Cystectomy 01/2022 - 01/2017
2	Immunotherapy 01/2022 - 01/2021
2	Erythrocyte Transfusion 03/2021 - 10/2020
2	Platelet Transfusion (Blood Platelet Transfusions) 12/2020 - 10/2018
2	Bariatric Surgery 01/2020 - 04/2014
1	Aftercare (After-Treatment) 01/2023